The Prevalence of Bronchodilator Responsiveness “Asthma” Among Adult Indigenous Australians Referred for Lung Function Testing in the Top End Northern Territory of Australia

References

• Global Initiative for Asthma. Global strategy for asthma management and prevention; 2021. Available from: www.ginasthma.org. Accessed May 22, 2022.
   Google Scholar
• To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. doi:10.1186/1471-2458-12-204
   PubMed Web of Science ®Google Scholar
• Saglani S, Menzie-Gow AN. Approaches to asthma diagnosis in children and adults. Front Pediatr. 2019;7:148. doi:10.3389/fped.2019.00148
   PubMed Web of Science ®Google Scholar
• Chapman DG, Irvin CG. Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come. Clin Exp Allergy. 2015;45(4):706–719. doi:10.1111/cea.12506
   PubMed Web of Science ®Google Scholar
• Cunningham J. Socioeconomic status and self-reported asthma in Indigenous and non-Indigenous Australian adults aged 18–64 years: analysis of national survey data. Int J Equity Health. 2010;9:18. doi:10.1186/1475-9276-9-18
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare 2020. Asthma. Cat. no. ACM 33. Canberra: AIHW. Available from: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/asthma. Accessed May 22, 2022.
   Google Scholar
• Kruavit A, Fox M, Pearson R, Heraganahally S. Chronic respiratory disease in the regional and remote population of the Northern Territory Top End: a perspective from the specialist respiratory outreach service. Aust J Rural Health. 2017;25:275–284.
   PubMed Web of Science ®Google Scholar
• Heraganahally S, Wasgewatta SL, McNamara K, et al. Chronic obstructive pulmonary disease in Aboriginal patients of The Northern Territory of Australia: a landscape perspective. Int J Chron Obstruct Pulmon Dis. 2019;14:2205–2217.
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Timothy TP, Sorger L. Chest computed tomography findings among adult Indigenous Australians in the Northern Territory of Australia. J Med Imaging Radiat Oncol. 2021. doi:10.1111/1754-9485.13295
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Wasgewatta SL, McNamara K, et al. Chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians – a comparative study. Int Med J. 2020;50(12):1505–1513. doi:10.1111/imj.14718
   Google Scholar
• Mehra S, Chang AB, Lam CK, et al. Bronchiectasis among Australian Aboriginal and non-Aboriginal patients in the regional and remote population of the Northern Territory of Australia. Rural Remote Health. 2021;21(2):6390. doi:10.22605/RRH6390
   PubMed Web of Science ®Google Scholar
• Colonna E, Maddox R, Cohen R, et al. Review of tobacco use among Aboriginal and Torres Strait Islander peoples. Austr Indigenous Health Bulletin. 2020;20(2): Available from: https://aodknowledgecentre.ecu.edu.au/learn/specific-drugs/tobacco/.
   Google Scholar
• Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198(8):1012–1020.
   PubMed Web of Science ®Google Scholar
• LindenSmith J, Morrison D, Deveau C, Hernandez P. Overdiagnosis of asthma in the community. Can Respir J. 2004;11(2):111–116.
   PubMedGoogle Scholar
• Kavanagh J, Jackson DJ, Kent BD. Over- and under-diagnosis in asthma. Breathe. 2019;15(1):e20–e27. doi:10.1183/20734735.0362-2018
   Web of Science ®Google Scholar
• Tay TR, Lee JWY, Hew M. Diagnosis of severe asthma. Med J Aust. 2018;209(2):S3–S10. doi:10.5694/mja18.00125
   PubMed Web of Science ®Google Scholar
• Veale AJ, Peat JK, Tovey ER, Salome CM, Thompson JE, Woolcock AJ. Asthma and atopy in four rural Australian aboriginal communities. Med J Aust. 1996;165(4):192–196. doi:10.5694/j.1326-5377.1996.tb124923.x
   PubMed Web of Science ®Google Scholar
• Cooksley NA, Atkinson D, Marks GB, et al. Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: the cross-sectional BOLD study. Respirology. 2015;20(5):766–774. doi:10.1111/resp.12482
   PubMed Web of Science ®Google Scholar
• Dawson AP. Asthma in the Australian Indigenous population: a review of the evidence. Rural Remote Health. 2004;4:238. doi:10.22605/RRH238
   PubMedGoogle Scholar
• Janson C, Malinovschi A, Amaral AFS, et al. Bronchodilator reversibility in asthma and COPD: findings from three large population studies. Eur Respir J. 2019;54:1900561. doi:10.1183/13993003.00561-2019
   PubMed Web of Science ®Google Scholar
• Nogrady SG, Evans WV, Davies BH. Reversibility of airways obstruction in bronchiectasis. Thorax. 1978;33(5):635–637. doi:10.1136/thx.33.5.635
   PubMed Web of Science ®Google Scholar
• Radovanovic D, Santusa P, Blasi F, et al. A comprehensive approach to lung function in bronchiectasis. Respir Med. 2018;145:120–129.
   PubMed Web of Science ®Google Scholar
• Mekov E, Nuñez A, Sin DD, et al. Update on asthma-COPD overlap (ACO): a narrative review. Int J Chron Obstruct Pulmon Dis. 2021;16:1783–1799. doi:10.2147/COPD.S312560
   PubMed Web of Science ®Google Scholar
• Hosseini M, Almasi-Hashiani A, Sepidarkish M, Maroufizadeh S. Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis. Respir Res. 2019;20(1):229. doi:10.1186/s12931-019-1198-4
   PubMed Web of Science ®Google Scholar
• Matsumoto H. Bronchiectasis in severe asthma and asthmatic components in bronchiectasis. Respir Investig. 2022;60(2):187–196. doi:10.1016/j.resinv.2021.11.004
   PubMed Web of Science ®Google Scholar
• Australian bureau of statistics. Estimates of aboriginal and torres strait Islander Australians. ABS, Canberra, Australia; 2016.
   Google Scholar
• Schubert J, Kruavit A, Mehra S, Wasgewatta S, Chang AB, Heraganahally SS. Prevalence and nature of lung function abnormalities among Indigenous Australians referred to specialist respiratory outreach clinics in the Northern Territory. Intern Med J. 2019;49(2):217–224.
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Howarth T, White E, Sorger L, Biancardi E, Ben Saad H. Lung function parameters among Australian Aboriginal “apparently healthy” adults: an Australian Caucasian and global lung function initiative (GLI-2012) various ethnic norms comparative study. Expert Rev Respir Med. 2020;23:1–11. doi:10.1080/17476348.2021.1847649
   Web of Science ®Google Scholar
• Heraganahally SS, Howarth T, Mo L, Sorger L, Saad HB. Critical analysis of spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases. Expert Rev Respir Med. 2021;15(9):1229–1238. doi:10.1080/17476348.2021.1928496
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Ponneri TR, Howarth TP, Saad HB. The effects of inhaled airway directed pharmacotherapy on decline in lung function parameters among Indigenous Australian adults with and without underlying airway disease. Int J Chron Obstruct Pulmon Dis. 2021;16:2707–2720.
   PubMed Web of Science ®Google Scholar
• Heraganahally S, Howarth TP, White E, Ben Saad H. Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study. BMJ Open Respir Res. 2021;8:e001135. doi:10.1136/bmjresp-2021-001135
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Howarth T, Sorger L, Ben Saad H. Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease. PLoS One. 2022;17(2):e0263744. doi:10.1371/journal.pone.0263744
   PubMed Web of Science ®Google Scholar
• Howarth TP, Saad HB, Perez AJ, Atos CB, White E, Heraganahally SS. Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults. PLoS One. 2021;16(4):e0248900. doi:10.1371/journal.pone.0248900
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338.
   PubMed Web of Science ®Google Scholar
• NDD Medical Technologies. EasyOne Pro. Andover MA 01810, USA; 2017.
   Google Scholar
• Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021. Available from: http://www.goldcopd.org. Accessed May 22, 2022.
   Google Scholar
• Sim YS, Lee JH, Lee WY, et al. Spirometry and bronchodilator test. Tuberc Respir Dis. 2017;80(2):105–112. doi:10.4046/trd.2017.80.2.105
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179–187.
   PubMed Web of Science ®Google Scholar
• Guezguez F, Knaz H, Anane I, Bougrida M, Ben Saad H. The ‘clinically significant’ bronchodilator responsiveness (BDR) in children: a comparative study between six definitions of scholarly societies and a mini-review. Expert Rev Respir Med. 2021;15(6):823–832. doi:10.1080/17476348.2021.1906653
   PubMed Web of Science ®Google Scholar
• Guezguez F, Ben Saad H. What constitutes a ”clinically significant” bronchodilator response in children? Eur Respir J. 2020;55(5):2000207. doi:10.1183/13993003.00207-2020
   PubMed Web of Science ®Google Scholar
• Chhabra SK. Clinical application of spirometry in asthma: why, when and how often? Lung India. 2015;32(6):635–637. doi:10.4103/0970-2113.168139
   PubMedGoogle Scholar
• Johnson JD, Theurer WM. A stepwise approach to the interpretation of pulmonary function tests. Am Fam Physician. 2014;89(5):359–366.
   PubMed Web of Science ®Google Scholar
• Pipavath SNJ, Schmidt RA, Takasugi JE, Godwin JD. Chronic obstructive pulmonary disease: radiology-pathology correlation. J Thorac Imaging. 2009;24(3):171–180.
   PubMed Web of Science ®Google Scholar
• Gaillard F, Weerakkody Y. Bronchiectasis. Reference article. Available from: Radiopaedia.org. Accessed August 1, 2022.
   Google Scholar
• Stanojevic S, Kaminsky DA, Miller M, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2021;23:2101499. doi:10.1183/13993003.01499-2021
   Web of Science ®Google Scholar
• National Health and Medical Research Council. Ethical conduct in research with Aboriginal and Torres Strait Islander Peoples and communities: guidelines for researchers and stakeholders. Canberra: Commonwealth of Australia; 2018. Available from: https://www.nhmrc.gov.au. Accessed May 22, 2022.
   Google Scholar
• Brock C, McGuane J. Determinants of asthma in Indigenous Australians: insights from epidemiology. Austr Indigenous Health Bulletin. 2018;18(2):12–20.
   Google Scholar
• Koleade A, Farrell J, Mugford G, Gao Z. Prevalence and risk factors of ACO (Asthma-COPD Overlap) in Aboriginal people. J Environ Public Health. 2018;9. doi:10.1155/2018/4657420
   Web of Science ®Google Scholar
• Ben Saad H, Préfaut C, Tabka Z, Zbidi A, Hayot M. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD. Pulm Pharmacol Ther. 2008;21(5):767–773.
   PubMed Web of Science ®Google Scholar
• Schermer T, Heijdra Y, Zadel S, et al. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med. 2007;101(6):1355–1362. doi:10.1016/j.rmed.2006.09.024
   PubMed Web of Science ®Google Scholar
• Vigna M, Aiello M, Bertorelli G, Crisafulli E, Chetta A. Flow and volume response to bronchodilator in patients with COPD. Acta Biomed. 2018;89(3):332–336. doi:10.23750/abm.v89i3.5631
   PubMedGoogle Scholar
• Dias RM, Chacur FH, Carvalho SR, Neves DD. Which functional parameters can help differentiate severe asthma from COPD? Rev Port Pneumol. 2010;16(2):253–272.
   PubMed Web of Science ®Google Scholar
• Ospina MB, Voaklander DC, Stickland MK. Prevalence of asthma and chronic obstructive pulmonary disease in Aboriginal and non-Aboriginal populations: a systematic review and meta-analysis of epidemiological studies. Can Respir J. 2012;19(6):355–360. doi:10.1155/2012/825107
   PubMed Web of Science ®Google Scholar
• Bird Y, Moraros J, Mahmood R, Esmaeelzadeh S, Kyaw Soe NM. Prevalence and associated factors of COPD among Aboriginal peoples in Canada: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2017;12:1915–1922. doi:10.2147/COPD.S138304
   PubMed Web of Science ®Google Scholar
• Sze DFL, Howarth TP, Lake CD, Ben Saad H, Heraganahally SS. Differences in the spirometry parameters between indigenous and non-indigenous patients with COPD: a matched control study. Int J Chron Obstruct Pulmon Dis. 2022;17:869–881.
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Silva SAMS, Howarth TP, Kangaharan N, Majoni SW. Comparison of clinical manifestation among Australian Indigenous and non‐ Indigenous patients presenting with pleural effusion. Int Med J. 2021. doi:10.1111/imj.15310
   Google Scholar
• Heraganahally SS, Mortimer N, Howarth T, et al. Utility and outcomes among Indigenous and non-Indigenous patients requiring domiciliary oxygen therapy in the regional and rural Australian population. Aust J Rural Health. 2021;29(6):918–926. doi:10.1111/ajr.12782
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Ghimire RM, Howarth T, Kankanamalage OM, Palmer D, Falhammar H. Comparison and outcomes of emergency department presentations with respiratory disorders among Australian indigenous and non-indigenous patients. BMC Emerg Med. 2022;22:11. doi:10.1186/s12873-022-00570-3
   PubMed Web of Science ®Google Scholar
• Seyedshahabedin MM, Howarth TP, Mo L, Biancardi E, Heraganahally SS. Flexible bronchoscopy indications and outcomes between Indigenous and non-Indigenous patients in the Northern Territory of Australia. Int Med J. 2022. doi:10.1111/imj.15865
   Google Scholar
• Heraganahally SS, Rajaratnam B, Silva SAAS, et al. Obstructive sleep apnoea and cardiac disease among aboriginal patients in the Northern Territory of Australia. Heart Lung Circ. 2021. doi:10.1016/j.hlc.2021.01.007
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Kruavit A, Oguoma VM, et al. Sleep apnoea among Australian Aboriginal and Non- Aboriginal patients in the Northern Territory of Australia– a comparative study. Sleep. 2020;43(3):zsz248. doi:10.1093/sleep/zsz248
   PubMed Web of Science ®Google Scholar
• La-Grappe D, Massey L, Kruavit A, et al. Sleep disorders among Aboriginal Australians with Machado-Joseph Disease: quantitative results from a multiple methods study to assess the experience of people living with the disease and their caregivers. Neurobiol Sleep Circadian Rhythms. 2022. doi:10.1016/j.nbscr.2022.100075
   PubMedGoogle Scholar
• Howarth TP, Gentin N, Reyes-Chicuellar N, et al. Sleep quality and obstructive sleep apnoea in Indigenous and non-Indigenous Australian children. Sleep Med. 2022;98:68–78. doi:10.1016/j.sleep.2022.06.014
   PubMed Web of Science ®Google Scholar
• Kann K, Long B, Koyfman A. Clinical mimics: an emergency medicine-focused review of asthma mimics. J Emerg Med. 2017;53(2):195–201. doi:10.1016/j.jemermed.2017.01.005
   PubMed Web of Science ®Google Scholar
• Reddel HK. Common conditions that mimic asthma. Med J Aust. 2022;216(7):337–340. doi:10.5694/mja2.51467
   PubMed Web of Science ®Google Scholar
• King CS, Moores LK. Clinical asthma syndromes and important asthma mimics. Respir Care. 2008;53(5):568–80;discussion 580–2.
   Web of Science ®Google Scholar
• Heraganahally SS, Ghataura AS, Er XY, Heraganahally S, Biancardi E. Excessive dynamic airway collapse: a COPD/Asthma mimic or a treatment emergent consequence of inhaled corticosteroid therapy - case series and brief literature review. Clin Pulm Med. 2020;27:175–182.
   Google Scholar
• Rogliani P, Ora J, Puxeddu E, Cazzola M. Airflow obstruction: is it asthma or is it COPD? Int J Chron Obstruct Pulmon Dis. 2016;11:3007–3013. doi:10.2147/COPD.S54927
   PubMed Web of Science ®Google Scholar
• Pal A, Howarth TH, Rissel C, et al. COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort– a study to explore preventable hospitalisation. BMJ Open Resp Res. 2022;9:e001295. doi:10.1136/bmjresp-2022-001295
   PubMed Web of Science ®Google Scholar